DEVICE · Unmapped registry intervention
Augmented-reality ICG fluorescence second-look imaging
Find medicine records ·
Find other trials using this name
Clinical trial
Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer
NCT07696754
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAugmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Breast Neoplasmsunresolved
Sentinel Lymph Nodeunresolved
Lymphatic Metastasisunresolved
Interventions
Sponsors & collaborators
Ss. Cyril and Methodius University of Skopjelead sponsor
University of Illinois at Urbana-Champaigncollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07696754 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.